The SIGMAR1 gene, associated with Amyotrophic Lateral Sclerosis type 16 (ALS16), plays a crucial role in the understanding and diagnosis of this specific form of ALS. Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and the spinal cord, leading to muscle weakness and, eventually, severe physical disability.
The genetic test for ALS16 focuses on mutations within the SIGMAR1 gene. Identifying these mutations can be pivotal for families with a history of ALS, as it provides crucial information regarding the inheritance pattern, potential risks to other family members, and contributes to the body of knowledge necessary for future therapeutic developments.
DNA Labs UAE offers this specialized genetic testing service. The test is priced at 4400 AED and is conducted in their state-of-the-art laboratory facilities. By opting for this test at DNA Labs UAE, patients and their families can expect a comprehensive analysis of the SIGMAR1 gene, which will aid in the diagnosis of ALS16. This information can be invaluable for making informed decisions about treatment options and managing the disease more effectively.
The CHMP2B Gene Amyotrophic Lateral Sclerosis Type 17 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CHMP2B gene that are linked to Amyotrophic Lateral Sclerosis (ALS) Type 17. ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and the spinal cord, leading to loss of muscle control. Type 17 ALS, associated with mutations in the CHMP2B gene, is a rare form of the disease that can be familial or sporadic. This genetic test plays a crucial role in the early detection and diagnosis of ALS Type 17, enabling healthcare professionals to devise appropriate management and treatment plans for affected individuals. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test is priced at 4400 AED. The accurate identification of CHMP2B gene mutations through this test is vital for understanding the disease's progression, potential familial risk, and exploring targeted therapeutic strategies.
The PFN1 Gene Amyotrophic Lateral Sclerosis Type 18 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the PFN1 gene, which have been associated with the development of Amyotrophic Lateral Sclerosis (ALS) type 18. ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and the spinal cord, leading to muscle weakness and, eventually, severe physical disability. The test aims to provide crucial genetic information for individuals who have a family history of ALS or are exhibiting symptoms of the disease, enabling early diagnosis and the opportunity for better management of the condition. The cost of the test is 4400 AED, reflecting the specialized technology and expertise required to accurately identify the genetic variations linked to this form of ALS. Conducted in the state-of-the-art facilities of DNA Labs UAE, this genetic test represents a significant step forward in the personalized care and management of ALS, offering hope and vital information to patients and their families.
The AAAS Gene Achalasia-Addisonianism-Alacrimia Syndrome Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE. This test is designed to detect mutations in the AAAS gene, which are implicated in the rare, autosomal recessive disorder known as Triple-A Syndrome (Achalasia-Addisonianism-Alacrimia Syndrome). Patients with this condition often exhibit a range of symptoms including esophageal achalasia, adrenal gland insufficiency (Addison's disease), and a decreased production of tears (alacrimia).
Given the complex nature of this syndrome and its significant impact on an individual's health, accurate diagnosis is crucial for appropriate management and treatment. The genetic test offered by DNA Labs UAE utilizes advanced molecular techniques to analyze the AAAS gene for any mutations that are known to cause the syndrome, providing a precise diagnosis that can guide treatment decisions and genetic counseling.
The cost of the AAAS Gene Achalasia-Addisonianism-Alacrimia Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the AAAS gene. By opting for this test, patients and their families can gain valuable insights into their genetic health, enabling them to take proactive steps in managing the condition and improving their quality of life.
The KIF7 gene plays a crucial role in the development of various bodily structures, including the limbs, brain, and facial features. Mutations in the KIF7 gene are associated with Acrocallosal syndrome, a rare genetic disorder characterized by craniofacial abnormalities, polydactyly (extra fingers or toes), intellectual disability, and in some cases, agenesis of the corpus callosum, which is the structure connecting the two hemispheres of the brain.
To diagnose Acrocallosal syndrome and confirm its association with mutations in the KIF7 gene, genetic testing is essential. DNA Labs UAE offers a comprehensive genetic test targeting the KIF7 gene to identify mutations linked to Acrocallosal syndrome. This test is pivotal for individuals exhibiting symptoms of the syndrome or those with a family history of genetic disorders.
The cost of the KIF7 gene genetic test at DNA Labs UAE is 3200 AED. This test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect mutations in the KIF7 gene. The results of this test can provide crucial information for diagnosis, management, and genetic counseling for affected individuals and their families.
The ACOX1 gene plays a critical role in the metabolism of fatty acids within the peroxisomes, a specialized compartment in the cell. Mutations in the ACOX1 gene can lead to a rare metabolic disorder known as Acyl-CoA Oxidase Deficiency. This condition disrupts the normal breakdown of long-chain fatty acids, leading to a buildup of toxic substances in the body, which can result in severe neurological and developmental issues.
To diagnose this condition, a genetic test targeting the ACOX1 gene can be conducted. DNA Labs UAE offers this specific test, providing a reliable means of diagnosing Acyl-CoA Oxidase Deficiency. The test involves analyzing the patient's DNA to identify mutations in the ACOX1 gene that are indicative of the disorder.
The cost of the ACOX1 Gene Acyl-CoA Peroxisomal Oxidase Deficiency Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the specialized nature of the test, the advanced technology used in the analysis, and the professional expertise required to interpret the results accurately. Once the test is conducted, healthcare providers can use the results to confirm a diagnosis, which is crucial for developing an effective treatment plan and managing the condition.
The ABCD1 Gene Adrenoleukodystrophy (ALD) X-Linked Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the ABCD1 gene, which are responsible for X-linked adrenoleukodystrophy. This genetic disorder affects the nervous system and adrenal glands, leading to a wide range of symptoms from difficulty in concentrating to severe physical disabilities. The test is particularly crucial for early detection and management of the condition, as well as for family planning purposes for those with a history of ALD. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test provides a comprehensive analysis of the ABCD1 gene to identify any aberrations. The cost of the test is 3200 AED, an investment towards understanding one's genetic health and taking proactive steps in managing the condition effectively.
The PLXNB3 Gene Adrenoleukodystrophy (ALD) X-linked Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the PLXNB3 gene that are associated with X-linked Adrenoleukodystrophy, a genetic disorder. This condition affects the nervous system and the adrenal glands, leading to a wide range of symptoms, including behavioral changes, loss of function in the adrenal gland, and progressive neurological decline. The test is crucial for early detection and management of the disorder, particularly in families with a history of ALD. Priced at 3200 AED, the test involves analyzing the patient's DNA to detect mutations in the PLXNB3 gene, providing essential information for diagnosis, treatment planning, and genetic counseling. DNA Labs UAE ensures a comprehensive and reliable testing process, employing advanced genetic testing technologies to assist patients and their families in managing this challenging condition.
The ABCD1 Gene Adrenoleukodystrophy/Adrenomyeloneuropathy Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to detect mutations in the ABCD1 gene. These mutations are responsible for a range of genetic disorders, including Adrenoleukodystrophy (ALD) and Adrenomyeloneuropathy (AMN), which are X-linked conditions affecting the nervous system and adrenal glands. The test, priced at 4400 AED, involves analyzing the patient's DNA to identify any abnormalities in the ABCD1 gene that could lead to these conditions. This test is crucial for early detection and management of ALD and AMN, potentially guiding treatment options and family planning decisions. DNA Labs UAE employs advanced genetic testing technologies to ensure accurate and reliable results, offering a critical resource for individuals and families at risk of these genetic disorders.
The SLC12A6 gene plays a crucial role in the development and function of the nervous system. Mutations in this gene can lead to a rare genetic disorder known as Agenesis of the Corpus Callosum with Peripheral Neuropathy (ACCPN). This condition is characterized by the absence or underdevelopment of the corpus callosum, the part of the brain that connects the two cerebral hemispheres, along with peripheral neuropathy, which affects the peripheral nerves.
To diagnose this condition, a genetic test focusing on the SLC12A6 gene can be conducted. DNA Labs UAE offers this specific genetic test to identify mutations in the SLC12A6 gene that are indicative of ACCPN. The test is crucial for accurate diagnosis and can aid in the management and treatment of the condition.
The cost of the SLC12A6 gene genetic test at DNA Labs UAE is 3200 AED. This test is a vital tool for families and individuals at risk of ACCPN, providing them with essential information for healthcare planning and intervention.
